MoonLake Immunotherapeutics MLTX Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $298.49M+9.9% | $334.52M+85.4% | $350.7M-6.7% | $306.7M-10.5% | $271.6M-40.8% | ||
| $59.43M-71.5% | $59.45M-77.8% | $29.74M-74.9% | $118.4M-33.1% | $208.56M+135% | ||
| $396.64M-21.7% | $421.69M-11.1% | $411.22M-19.7% | $455.48M-15.2% | $506.26M-8.5% | ||
| $532K-25.2% | $577K-20.1% | $622K+7.0% | $667K+38.5% | $711K+39.5% | ||
| $3.73M-25.3% | $2.74M-24.8% | $3.12M-47.1% | $4.62M-42.3% | $5M-52.5% | ||
| $400.37M-21.7% | $424.43M-11.2% | $414.34M-20.0% | $460.1M-15.6% | $511.26M-9.4% | ||
| $46.11M+92.3% | $45.48M+102% | $48.37M+141% | $27.36M+123% | $23.98M+169% | ||
| $99.02M— | $74.1M— | $73.74M— | —— | —— | ||
| $100.24M+34.2% | $74.47M+3,482% | $74.78M+2,742% | $74.79M+2,817% | $74.7M+2,549% | ||
| $146.35M+48.3% | $119.95M+389% | $123.14M+442% | $102.15M+588% | $98.68M+741% | ||
| -$532.62M-93.3% | -$462.91M-96.5% | -$400.49M-111% | -$330.76M-114% | -$275.54M-111% | ||
| $254.02M-37.7% | $304.48M-31.9% | $288.91M-40.8% | $353.73M-32.1% | $407.52M-24.9% | ||
| $400.37M-21.7% | $424.43M-11.2% | $414.34M-20.0% | $460.1M-15.6% | $511.26M-9.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MoonLake Immunotherapeutics's total assets?
- MoonLake Immunotherapeutics (MLTX) holds $400.4M in total assets, down 21.7% year over year.
- How much debt does MoonLake Immunotherapeutics have?
- MoonLake Immunotherapeutics carries $100.8M in total debt against $254.0M of shareholders' equity, a debt-to-equity ratio of 0.40.
- How much cash does MoonLake Immunotherapeutics have?
- MoonLake Immunotherapeutics holds $298.5M in cash and equivalents.
- Can MoonLake Immunotherapeutics cover its short-term obligations?
- Its current ratio is 8.60 — current assets exceed current liabilities.
- Where does MoonLake Immunotherapeutics's balance sheet data come from?
- Every line is extracted from MoonLake Immunotherapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.